Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome

Description

The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.

Conditions

Twin to Twin Transfusion as Antepartum Condition, Monochorionic Diamniotic Placenta

Study Overview

Study Details

Study overview

The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome (TTTS)

Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome

Condition
Twin to Twin Transfusion as Antepartum Condition
Intervention / Treatment

-

Contacts and Locations

Seattle

Seattle Childrens Hospital, Seattle, Washington, United States, 98015

Seattle

University of Washington, Seattle, Washington, United States, 98195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Single placenta (Monochorionic)
  • * Polyhydramnios present in recipient twin (Greater than 8 cm maximum vertical pocket below 20 weeks and greater than a 10 cm pocket for greater than 20 weeks gestational age)
  • * Oligohydramnios present in donor twin (Less than 2 cm maximum vertical pocket)
  • * Prominent bladder in the recipient/ non-filling bladder in the donor
  • * Thin dividing membrane
  • * Patients unwilling to participate in the study or to be followed up
  • * Presence of major congenital anomalies incompatible with survival
  • * Active pre-term labor Ruptured membranes
  • * Chorioamnionitis
  • * Vaginal bleeding

Ages Eligible for Study

to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Seattle Children's Hospital,

Martin P Walker, MD, PRINCIPAL_INVESTIGATOR, Seattle Childrens Hospital

Study Record Dates

2031-10-01